AI and Ozempic: The two great disruptive technologies of 2023

AI is poised to upend the music industry, and Fast Company Associate Editor David Salazar joins us to discuss what AI generative music is and how the music industry is combating it. Antidiabetic medication Ozempic is all over the news these days, but it's not as new as it seems. Beyond the TikTok trends and celebrity shout-outs, it's been used to treat diabetes for years. But now talk of this medication has reached a fever pitch. Found CEO Sarah Jones Simmer talks about how her company prioritizes comprehensive weight care management, the ongoing discussion about Ozempic, and the very complicated history of weight in this country. Basically, how do we thread the needle between self-acceptance and positive body image and the existing health challenges, like the skyrocketing rates of diabetes? Then we discuss Barbenheimer because, well, we have to.

Om Podcasten

Fast Company deputy editor Kathleen Davis takes listeners on a journey through the changing landscape of our work lives. Each episode explores the future of work, including the state of remote and hybrid work amid the return-to-office battle; how AI will change the way we do our jobs; the status of gender equity and DEI efforts; rethinking career ladders and ambition; motivation and what makes work meaningful; and the progress on mental health and disability issues at work. And as if all that isn’t enough, she also shares practical advice for interviews, résumés, and salary negotiations, as well as the latest office jargon, just how useful personality tests really are, and more.